Patent ID: 11897944
Assignee: ABLYNX N.V.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 14:
15. The polypeptide according to claim 14:
wherein the polypeptide comprises an ISVD having: a leucine (L), a lysine (K), or a valine (V) at Kabat position 11; an alanine (A) or a proline (P) at Kabat position 14; an alanine (A), a leucine (L), a proline (P), a serine (S), or a threonine (T) at Kabat position 41; a glutamic 11475485.1 acid (E) or a glycine (G) at Kabat position 42; an alanine (A) or a threonine at Kabat position 87; an alanine (A), a leucine (L), or a threonine at Kabat position 89; a leucine (L) at Kabat position 108; a lysine (K) or a glutamine (Q) at Kabat position 110; a lysine (K) or a glutamine (Q) at Kabat position 112; or a combination thereof.